Altus Pharmaceuticals Appoints Alan Kimura, M.D., Ph.D. Vice President, Clinical Development and Medical Affairs.CAMBRIDGE, Mass. -- Altus(R) Pharmaceuticals Inc., a leader in the development of novel protein therapies to treat chronic gastrointestinal and metabolic diseases, announced today that Alan Kimura, M.D., Ph.D. has been appointed Vice President, Clinical Development and Medical Affairs. In this new position, Dr. Kimura will lead Altus' Medical and Clinical Affairs groups which oversees clinical development and all medical-related activities for Altus' portfolio of clinical products and drug candidates. "Alan brings to Altus extensive experience from a 16-year drug development career in both large pharmaceutical organizations and small biotech companies," said John Richard John D. Richard Q.C. (born July 30, 1934) is the Chief Justice of Canada's Federal Court of Appeal. Richard was born in Ottawa and received a Bachelor of Arts degree in Political Science from the University of Ottawa in 1955, followed by his law studies at Osgoode Hall Law , Chairman of the Board at Altus. "Alan understands the rigor rigor /rig·or/ (rig´er) [L.] chill; rigidity. rigor mor´tis the stiffening of a dead body accompanying depletion of adenosine triphosphate in the muscle fibers. and process of developing biopharmaceutical drugs. His experience and knowledge of the clinical and regulatory processes will be valuable to Altus as we continue to develop and grow our pipeline of novel protein therapeutics. I am excited to welcome Alan to our already strong management team and feel his leadership will be of tremendous value as we move multiple programs into early and late-stage clinical development." Prior to joining Altus, Dr. Kimura was Executive Director, Clinical Affairs at Transkaryotic Therapies (TKT TKT Ticket TKT Transketolase TKT Twisted Kaiju Theater (web forum) TKT T Kang Taekwondo (New York) TKT Thin Kerf Technologies ) where he was involved in the clinical development of protein-based therapies for rare genetic diseases. Before joining TKT, Dr. Kimura held various positions in Clinical Research and Medical Affairs at Biochem Pharma, Smithkline Beecham Biologicals and the Wyeth-Lederle Vaccines division of American Home Products. Following the completion of his postdoctoral work, Dr. Kimura held Bacteriology bacteriology Study of bacteria. Modern understanding of bacterial forms dates from Ferdinand Cohn's classifications. Other researchers, such as Louis Pasteur, established the connection between bacteria and fermentation and disease. Research positions in the Research Departments of the Praxis Biologicals and Lederle Biologicals divisions of American Cyanamid. Dr. Kimura received his M.D. from University of Miami This article is about the university in Coral Gables, Florida. For the university in Oxford, Ohio, see Miami University. The University of Miami (also known as Miami of Florida,[2] UM,[3] or just The U School of Medicine. He received a Ph.D and M.S. in Microbiology from University of California, Davis The University of California, Davis, commonly known as UC Davis, is one of the ten campuses of the University of California, and was established as the University Farm in 1905. and a B.A. in Bacteriology from University of California, Berkeley The University of California, Berkeley is a public research university located in Berkeley, California, United States. Commonly referred to as UC Berkeley, Berkeley and Cal . About Altus Pharmaceuticals Inc. Altus Pharmaceuticals is focused on developing and commercializing novel protein therapeutics for patients with chronic gastrointestinal and metabolic diseases. Altus' in-depth knowledge of protein crystallization Crystallization The formation of a solid from a solution, melt, vapor, or a different solid phase. Crystallization from solution is an important industrial operation because of the large number of materials marketed as crystalline particles. has resulted in a proprietary pipeline of orally delivered and injectable protein replacement products. As a company, Altus is committed to improving the quality of life of patients. More information about Altus and its clinical development programs can be found at www.altus.com. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion